Clinical Trial Details

A Global Phase III Study of Puxitatug Samrotecan (AZD8205) Monotherapy Compared with Physician’s Choice of Chemotherapy for B7-H4-Selected Endometrial Cancer that Progressed Following Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy. (BLUESTAR-Endometrial01)

IRB Protocol Number
GOG 3110

Clinical Trial Categories

  • Endometrial Cancer
Contact
Clinical Trials at 910-715-2200

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.